zidovudine has been researched along with sodium azide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhutani, KK; Bodiwala, HS; Garg, P; Gupta, P; Kumar, R; Mitra, D; Mukherjee, R; Sabde, S; Singh, IP | 1 |
| Gollapudi, S; Gupta, S | 1 |
| Breimer, DD; de Boer, AG; Jaehde, U; Langemeijer, MW; Masereeuw, R | 1 |
3 other study(ies) available for zidovudine and sodium azide
| Article | Year |
|---|---|
Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.
Topics: Acetanilides; Anilides; Anti-HIV Agents; Caffeic Acids; CCR5 Receptor Antagonists; Drug Design; HIV Integrase Inhibitors; HIV-1; Ligands; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Virus Replication | 2011 |
Human immunodeficiency virus I-induced expression of P-glycoprotein.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biological Transport; Cell Line; Cell Transformation, Viral; Cyclosporins; Daunorubicin; Drug Resistance; Flow Cytometry; HIV-1; Humans; Membrane Glycoproteins; Membrane Potentials; Sodium Azide; Zidovudine | 1990 |
In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors.
Topics: Analysis of Variance; Animals; Azides; Blood-Brain Barrier; Brain; Cattle; Cells, Cultured; Central Nervous System; Deoxyglucose; Diffusion; Endothelium, Vascular; Injections, Intravenous; Injections, Intraventricular; Male; Probenecid; Rats; Rats, Wistar; Sodium Azide; Thymidine; Zidovudine | 1994 |